KCAS Bio is proud to announce our attendance at the Paris Saclay Cancer Cluster (PSCC) Innovation Forum 2026, taking place in Villejuif, France, on February 4, 2026. This event is a one-day oncology-focused meeting centered on innovation, scientific exchange, and ecosystem collaboration. The program includes expert talks on recent breakthroughs in cancer research and care, start-up pitches from PSCC-supported companies, and case studies highlighting collaborations between SMEs, large companies, and investors in the biotech and medtech sectors. Structured networking sessions bring together participants from academia, industry, investment, and public institutions.
Supporting Oncology Drug Development
KCAS Bio supports oncology drug development with bioanalytical services across preclinical and clinical stages, including emerging modalities such as antibody–drug conjugates, cell and gene therapies, bispecific antibodies, and targeted protein degraders. Our expertise in pharmacokinetics, biomarkers, immunogenicity, and advanced flow cytometry supports mechanism-of-action studies, efficacy evaluation, and patient stratification.
Connect with KCAS Bio in Villejuif
We invite you to connect with KCAS Bio at the PSCC Innovation Forum 2026. Let’s discuss how our bioanalytical expertise can support your research and development initiatives. Whether you are exploring biomarkers, optimizing therapeutic approaches, or advancing to clinical trials, KCAS Bio is here to help you achieve your objectives. Contact us today to schedule a meeting during the conference. Together, we can drive innovation and make a lasting impact on the lives of patients worldwide.